Engineering and Development

Chief Financial Officer

Head of Research & Development/Chief Medical Officer

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - October 3, 2025

Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule

OGT Assay Nabs FDA Authorization as CDx for Syndax's Revuforj in Acute Leukemia

Syndax’s Revuforj® (revumenib) Included in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for the Treatment of Relapsed or Refractory NPM1 Mutated Acute Myeloid Leukemia

Director, Biostatistics

Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. The Director of Biostatistics will provide expertise and guidance in study design and analyses while collaborating with cross-functional teams to ensure high quality and timely deliverables for clinical projects and studies.

Director, Head of Compensation and Benefits

Talent Acquisition Partner | TSP Talent Solutions RPO

Associate Director, Biostatistics

Director Biostatistics

Sign up with Google

Sign in with Google